Previous 10 | Next 10 |
2023-12-19 11:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-07 15:00:00 ET Summary Welcome to another installment of our monthly Rare Stock Picks series. Today we're highlighting November 2023 investment picks you may have missed. As you know, some Seeking Alpha analysts are more discerning by nature. Others are finding compelling ...
IRVINE, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the first patient enrollment in the PEERLESS ...
IRVINE, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the close of its acquisition of LimFlow S.A....
2023-11-07 08:02:49 ET Summary Inari Medical's Q3 2023 revenue was up over 31% YoY, with $3.2M in net income and $351.3M in cash and investments. The acquisition of LimFlow presents a potential $1.5B annual opportunity in the US for Inari Medical. Despite competition and poten...
2023-11-01 23:27:12 ET Inari Medical, Inc. (NARI) Q3 2023 Earnings Conference Call November 01, 2023 04:30 PM ET Company Participants John Hsu - VP, IR Drew Hykes - President and CEO Mitch Hill - CFO Tom Tu - CMO Conference Call Participants Kallu...
2023-11-01 16:17:29 ET Inari Medical press release ( NASDAQ: NARI ): Q3 GAAP EPS of $0.05 beats by $0.05 . Revenue of $126.4M (+31.4% Y/Y) beats by $4.43M . For the full year 2023, we are raising our revenue guidance to a range of $490 million to $493 million. ...
2023-11-01 16:11:02 ET More on Inari Medical Inari Medical: A Balanced Opportunity Amid Risks Inari Medical director sells stock worth $1.4M - filing Seeking Alpha’s Quant Rating on Inari Medical Historical earnings data for Inari Medical Finan...
IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its third quarter ended...
Announces Q3 2023 Financial Results Inari to Host Conference Call Today at 1:30 P.M PT / 4:30 P.M. ET IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the li...
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
SAN FRANCISCO, June 27, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now . Class Period: Feb. 24, 2022 – Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...